DXR

- · NASDAQ

Sector -
Industry -
Website daxor.com
Employees(FY) -
ISIN -

Performance

-0.14%

-19.17%

-21.12%

-6.24%

YTD

-15.18%

Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Advanced Technical Analysis

Technical Analysis of DXR 2025-02-26

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 0 indicating strong downward pressure, while the Oscillators Score of 45 suggests a neutral stance that may not provide sufficient support. The Technical Score of 22 further reinforces the bearish outlook, indicating a lack of momentum for upward price movem...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of DXR

Stock Rank

Recent News & Updates

2025-02-26 19:00
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals(Globenewswire)
2025-02-18 19:00
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025(Globenewswire)
2025-02-17 19:00
Daxor to Exhibit at World's Largest Critical Care Conference(Globenewswire)
2025-02-13 19:00
Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment(Globenewswire)
2025-02-12 19:00
New Multicenter Study Highlights Utility of Daxor's Blood Volume Analysis in Heart Failure Care(Globenewswire)
2024-12-17 19:00
Daxor Expands Its BVA-100 Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum(Globenewswire)
2024-10-08 20:00
DAXOR'S INNOVATIVE BVA-100 BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24(Globenewswire)
2024-10-07 20:00
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit(Globenewswire)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.